Iveda Solutions Warrant
IVDAW
5 hedge funds and large institutions have $52.4K invested in Iveda Solutions Warrant in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0.09% more ownership
Funds ownership: 8.81% → 8.9% (+0.09%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
26% less capital invested
Capital invested by funds: $70.4K → $52.4K (-$18K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$249 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$12 |
IVDAW Hedge Fund Activity: Q3 2025 in Review
5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Iveda Solutions Warrant (IVDAW) for Q3 2025, worth a combined $52.4K — down 26% from $70.4K a quarter earlier.
Fund positioning in IVDAW was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $249. The largest seller was Clear Street, cutting an estimated $12.
- 5 institutional investors held Iveda Solutions Warrant (IVDAW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $52.4K of Iveda Solutions Warrant stock for Q3 2025, down 26% quarter-over-quarter.
- 0 funds opened new Iveda Solutions Warrant positions in Q3 2025 and 0 closed out.
- The largest Iveda Solutions Warrant buyer in Q3 2025 was UBS Group, an estimated $249 added.
- The largest Iveda Solutions Warrant seller in Q3 2025 was Clear Street, an estimated $12 sold.
Based on aggregated 13F filings for Q3 2025.